NJ State Employees Deferred Compensation Plan’s Pfizer PFE Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51,956	Closed	-$1.32M	–	296
2025 Q3	$1.32M	Hold	51,956	–	–	0.15%	148
2025 Q2	$1.26M	Hold	51,956	–	–	0.15%	150
2025 Q1	$1.32M	Hold	51,956	–	–	0.17%	143
2024 Q4	$1.38M	Hold	51,956	–	–	0.17%	139
2024 Q3	$1.5M	Hold	51,956	–	–	0.18%	130
2024 Q2	$1.45M	Hold	51,956	–	–	0.18%	122
2024 Q1	$1.44M	Hold	51,956	–	–	0.18%	122
2023 Q4	$1.5M	Hold	51,956	–	–	0.21%	110
2023 Q3	$1.72M	Hold	51,956	–	–	0.26%	94
2023 Q2	$1.91M	Hold	51,956	–	–	0.28%	83
2023 Q1	$2.12M	Hold	51,956	–	–	0.33%	73
2022 Q4	$2.66M	Hold	51,956	–	–	0.43%	62
2022 Q3	$2.27M	Hold	51,956	–	–	0.39%	65
2022 Q2	$2.72M	Hold	51,956	–	–	0.44%	60
2022 Q1	$2.69M	Hold	51,956	–	–	0.36%	72
2021 Q4	$3.07M	Hold	51,956	–	–	0.39%	67
2021 Q3	$2.23M	Hold	51,956	–	–	0.3%	81
2021 Q2	$2.04M	Hold	51,956	–	–	0.27%	92
2021 Q1	$1.88M	Hold	51,956	–	–	0.27%	93
2020 Q4	$1.91M	Sell	51,956 -2,806	-5%	-$103K	0.3%	87
2020 Q3	$1.91M	Hold	54,762	–	–	0.34%	76
2020 Q2	$1.7M	Hold	54,762	–	–	0.32%	79
2020 Q1	$1.7M	Hold	54,762	–	–	0.39%	67
2019 Q4	$2.04M	Hold	54,762	–	–	0.35%	75
2019 Q3	$1.87M	Sell	54,762 -12,648	-19%	-$460K	0.34%	76
2019 Q2	$2.77M	Hold	67,410	–	–	0.5%	43
2019 Q1	$2.72M	Sell	67,410 -40,052	-37%	-$1.6M	0.49%	44
2018 Q4	$4.45M	Hold	107,462	–	–	0.93%	19
2018 Q3	$4.49M	Hold	107,462	–	–	0.77%	19
2018 Q2	$3.7M	Sell	107,462 -14,756	-12%	-$504K	0.66%	26
2018 Q1	$4.12M	Hold	122,218	–	–	0.73%	22
2017 Q4	$4.2M	Hold	122,218	–	–	0.73%	24
2017 Q3	$4.14M	Hold	122,218	–	–	0.75%	19
2017 Q2	$3.9M	Hold	122,218	–	–	0.74%	20
2017 Q1	$3.97M	Hold	122,218	–	–	0.75%	19
2016 Q4	$3.77M	Hold	122,218	–	–	0.75%	19
2016 Q3	$3.93M	Hold	122,218	–	–	0.81%	16
2016 Q2	$4.08M	Hold	122,218	–	–	0.87%	15
2016 Q1	$3.82M	Hold	122,218	–	–	0.81%	16
2015 Q4	$3.74M	Hold	122,218	–	–	0.77%	21
2015 Q3	$3.64M	Sell	122,218 -36,890	-23%	-$1.18M	0.79%	18
2015 Q2	$5.06M	Hold	159,108	–	–	0.99%	10
2015 Q1	$5.25M	Hold	159,108	–	–	1.01%	9
2014 Q4	$4.7M	Hold	159,108	–	–	0.92%	12
2014 Q3	$4.46M	Hold	159,108	–	–	0.91%	13
2014 Q2	$4.48M	Hold	159,108	–	–	0.89%	14
2014 Q1	$4.85M	Hold	159,108	–	–	1%	11
2013 Q4	$4.62M	Hold	159,108	–	–	0.94%	10
2013 Q3	$4.34M	Hold	159,108	–	–	0.95%	10
2013 Q2	$4.23M	Buy	+159,108	New	+$4.4M	0.97%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's PFE Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Pfizer (PFE) in Q4 2025, closing a stake of 51,956 shares — an estimated $1.32M sold.

NJ State Employees Deferred Compensation Plan first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $5.25M in Q1 2015. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 51,956 Pfizer shares in Q4 2025, an estimated $1.32M.
NJ State Employees Deferred Compensation Plan first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Pfizer position peaked at $5.25M in Q1 2015.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.